How to transfer my Wegovy prescription to Pennsylvania

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve likely wondered: Can I actually get these prescribed through telehealth? The short answer is yes—in most cases, you can legally receive GLP-1 weight loss medications through a telehealth consultation in the United States. But as with most healthcare matters, the details matter.

This guide breaks down everything you need to know about accessing weight loss medications via telehealth in 2025, including federal and state regulations, what to expect during your consultation, and how to ensure you’re working with a legitimate provider.

Understanding the Basics: Telehealth and Weight Loss Medications

What Are GLP-1 Medications?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed for Type 2 diabetes that have proven remarkably effective for weight management. The most commonly prescribed include:

• Wegovy (semaglutide 2.4mg) – FDA-approved specifically for chronic weight management
• Ozempic (semaglutide 0.5-1mg) – FDA-approved for diabetes, frequently prescribed off-label for weight loss
• Mounjaro/Zepbound (tirzepatide) – FDA-approved for both diabetes and obesity

These medications work by mimicking natural hormones that regulate appetite and blood sugar, helping patients feel fuller longer and consume fewer calories. Clinical trials have shown average weight loss of 15-20% of body weight over 68 weeks when combined with lifestyle modifications.

Why Telehealth Works for Weight Loss Treatment

Unlike controlled substances that fall under strict DEA regulations, GLP-1 medications are not classified as controlled substances. This is a crucial distinction that makes telehealth prescribing straightforward under federal law.

The Ryan Haight Act—the federal law requiring an in-person examination before prescribing controlled substances via telehealth—simply doesn’t apply to medications like Wegovy or Ozempic. This means that from a federal regulatory standpoint, a qualified healthcare provider can evaluate you via video consultation and send your prescription electronically to a pharmacy.

During the COVID-19 pandemic, telehealth expanded dramatically across all areas of medicine, including weight management. What many people don’t realize is that while temporary flexibilities for controlled medications (like Adderall) have been extended through December 31, 2025, non-controlled medications like GLP-1s have always been prescribable via telehealth—no special waivers needed.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Regulations: What You Need to Know

The federal regulatory landscape for telehealth prescribing has evolved significantly, especially since 2020. Here’s where things stand as of late 2025:

For GLP-1 Weight Loss Medications:

• ✅ No federal in-person requirement – The DEA’s Ryan Haight Act does not restrict these medications
• ✅ Permanent telehealth access – Unlike controlled substances, there’s no temporary waiver that could expire
• ✅ Standard of care applies – Providers must establish a legitimate patient-provider relationship through a proper evaluation

Current Status of DEA Telehealth Flexibilities:While not directly affecting GLP-1 medications, it’s worth noting that the DEA has extended COVID-era telehealth flexibilities for controlled substances through December 31, 2025. This extension demonstrates the federal government’s ongoing support for telehealth access, with further extensions or permanent rules expected in 2026.

State-by-State Variations: Where Things Get Specific

While federal law permits telehealth prescribing of weight loss medications, individual states can impose additional requirements. Some states require initial in-person examinations, mandate specific follow-up schedules, or have particular protocols for obesity treatment.

States Requiring Initial In-Person Exams

Several states mandate that patients complete an initial physical examination in person before continuing with telehealth care for weight loss medications:

Arkansas – One of the most restrictive telehealth states, Arkansas requires an initial in-person encounter to establish the patient-provider relationship. Proposals to ease these restrictions have been under review as of late 2025.

Delaware – An initial physical exam must be completed in person before prescribing weight loss medications via telehealth. After the initial visit, ongoing care can be managed remotely.

Georgia – State policy requires an in-person exam prior to telehealth prescribing. However, Georgia recently expanded prescriptive authority: as of July 2024, nurse practitioners and physician assistants can now prescribe Schedule II controlled substances with physician delegation (though GLP-1s aren’t affected by this classification).

Mississippi – Historically requires an initial in-person evaluation for weight management therapy. There’s an ongoing push to expand nurse practitioner independence, which could affect telehealth access.

New Jersey – Has particularly strict requirements for weight-loss prescriptions. The state Board of Medicine mandates a comprehensive initial evaluation including full medical history, physical examination, laboratory work, and psychological screening. Providers must also document informed consent covering all risks and develop a personalized diet and exercise plan.

North Dakota – Expects a hands-on initial evaluation for weight-loss treatment, per state medical board guidance. After the initial assessment, telehealth follow-ups are permitted.

South Carolina – State obesity treatment policy requires an initial in-person visit and periodic evaluations. Follow-up care can incorporate telehealth after the initial assessment.

Texas – While telehealth is broadly allowed, the standard of care typically dictates an initial in-person exam for weight loss medication. Texas has particularly strict oversight of prescriptive authority, with nurse practitioners requiring physician agreements and unable to prescribe certain controlled substances independently.

Virginia – Board of Medicine rules require an initial physical exam, lab work, and a personalized diet/exercise plan for any weight-loss drug. Additionally, Virginia mandates follow-up within 30 days of starting therapy.

States With More Flexible Telehealth Options

Many states have embraced telehealth for weight management with fewer restrictions:

California – No in-person requirement; telehealth evaluations are sufficient. California’s nurse practitioners gained full practice authority through AB 890, meaning experienced NPs can practice independently without physician oversight.

Connecticut – Permanent telehealth law allows remote prescribing without in-person mandates. However, state regulations require providers to include behavioral counseling and a diet/exercise plan as part of obesity treatment.

Florida – No in-person exam required, but state law imposes specific conditions: patients must have a BMI ≥30 and attend follow-up visits at least every three months during treatment. Nurse practitioners may practice autonomously only in primary care settings.

Illinois – No special in-person requirements beyond establishing a proper patient-provider relationship. The state mandates electronic prescribing for all medications.

New York – Telehealth exam is sufficient; no in-person mandate. New York’s nurse practitioners gained full practice authority in 2022 after completing 3,600 hours of experience.

Pennsylvania – No in-person requirement for GLP-1 medications. However, nurse practitioners still require physician collaboration agreements under current law.

Washington – A pioneer in telehealth policy with no in-person requirements. Washington has full nurse practitioner independence. The state’s My Health My Data Act (effective 2023) adds extra privacy protections particularly relevant for sensitive weight-loss data.

States With Special Requirements

Utah – While an initial in-person exam is encouraged, it’s not strictly mandated. Utah expanded nurse practitioner autonomy with a 2023 law granting full practice authority.

Who Can Prescribe Weight Loss Medications via Telehealth?

The qualifications of your telehealth provider matter significantly and vary by state.

Physicians (MDs and DOs)

All states allow licensed physicians to prescribe GLP-1 medications via telehealth, provided they’re licensed in the state where the patient is physically located during the consultation. Physicians have full prescriptive authority for these medications nationwide.

Nurse Practitioners (NPs)

Nurse practitioner authority varies dramatically by state:

Full Practice Authority (34 states + DC as of 2025): In these states, experienced NPs can practice independently without physician oversight. States include:

• California, Washington, New York, Connecticut, Delaware, Illinois
• Recently added: Utah (2023), Michigan and Indiana (2024)

Reduced/Collaborative Practice (Remaining states): NPs must have a collaboration agreement or supervisory arrangement with a physician. Examples include:

• Texas (requires physician delegation agreement)
• Pennsylvania (collaboration required despite 2016 law awaiting implementation)
• Florida (limited independence in primary care only)

Evolving Landscape: Several states, including Mississippi and Pennsylvania, have pending legislation to expand nurse practitioner independence, which would increase telehealth access to weight loss care.

Physician Assistants (PAs)

Physician assistants can prescribe GLP-1 medications in all states, but typically require a supervising physician or collaborative practice agreement. The level of autonomy varies by state, with some allowing more independent practice than others.

What This Means for Patients

When you consult with a telehealth provider, you may see an MD, DO, NP, or PA depending on your state and the provider’s credentials. All of these professionals can legally prescribe weight loss medications when practicing within their state’s scope of practice.

Reputable telehealth platforms like Klarity Health work exclusively with appropriately licensed and credentialed providers, ensuring that whoever evaluates you has the legal authority to prescribe in your state.

The Telehealth Consultation Process: What to Expect

If you’re considering telehealth for weight loss medication, here’s what a legitimate process typically involves:

1. Initial Screening and Questionnaire

Expect to complete a comprehensive medical questionnaire covering:

• Current height and weight (to calculate BMI)
• Complete medical history, including cardiovascular conditions, thyroid issues, digestive disorders
• Current medications and allergies
• Previous weight loss attempts
• Family medical history, particularly thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Lifestyle factors including diet, exercise, sleep, and stress

Red flag: Any service that guarantees a prescription before reviewing your medical information or doesn’t require detailed health history is not following proper medical protocols.

2. Live Video Consultation

A licensed healthcare provider will meet with you via secure video to:

• Review your medical history and weight loss goals
• Discuss previous weight management efforts
• Explain how GLP-1 medications work, including expected results
• Cover potential side effects (commonly nausea, vomiting, diarrhea, constipation)
• Review serious contraindications (pregnancy, history of medullary thyroid carcinoma, pancreatitis, etc.)
• Discuss the importance of lifestyle modifications alongside medication
• Determine if you’re a suitable candidate

Most consultations last 20-45 minutes. Your provider should take time to answer questions and ensure you understand the treatment plan.

3. Clinical Qualification Assessment

To qualify for GLP-1 weight loss medications, you generally need to meet FDA-approved criteria:

• BMI ≥30 (obesity), OR
• BMI ≥27 with at least one weight-related comorbidity such as:
• Type 2 diabetes or prediabetes
• Hypertension
• High cholesterol
• Obstructive sleep apnea
• Cardiovascular disease

You’ll typically be disqualified if you have:

• Personal or family history of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current or planned pregnancy
• Active pancreatitis or history of severe pancreatitis
• Severe gastrointestinal disease
• History of diabetic retinopathy (for some formulations)

4. Prescription and Pharmacy Coordination

If approved, your provider will:

• Send an electronic prescription directly to a licensed pharmacy (most states now require e-prescribing)
• Provide detailed instructions on injection technique and dose titration
• Schedule follow-up appointments
• Discuss what to do if side effects occur

Important: Legitimate providers prescribe only FDA-approved branded medications (Wegovy, Ozempic, Mounjaro/Zepbound) from licensed U.S. pharmacies. As of May 2025, the FDA banned routine compounding of semaglutide due to safety concerns.

5. Ongoing Monitoring and Follow-up

Responsible telehealth care includes regular follow-up:

• First month: Check-in to assess tolerance and side effects
• Ongoing: Visits every 1-3 months to monitor weight loss, adjust dosage, and renew prescriptions
• Lab work: Periodic blood tests may be recommended (metabolic panel, liver function, lipid panel)

Some states legally mandate follow-up frequency. For example:

• Florida requires patients to be seen at least every three months
• Virginia requires a 30-day follow-up after starting therapy

Insurance Coverage and Costs

Insurance Coverage for Telehealth Weight Loss Treatment

Insurance coverage for GLP-1 medications varies significantly:

Medicare: Currently does not cover weight loss medications, though recent legislative efforts have proposed changing this policy. Medicare does cover obesity counseling and some telehealth services.

Commercial Insurance: Many plans now cover Wegovy and Zepbound (the obesity-indicated formulations) but often with restrictions:

• Prior authorization requirements
• Step therapy (must try other treatments first)
• High copays or coinsurance
• Limits on duration of coverage

Medicaid: Coverage varies by state. Some states cover obesity medications, while others do not.

Telehealth Visit Costs

The cost for telehealth consultations ranges widely:

• Initial consultation: $50-$200
• Follow-up visits: $40-$150
• Some platforms charge monthly subscription fees ($99-$299/month) that include medication, shipping, and provider visits

At Klarity Health, we accept both insurance and offer transparent cash-pay options, making weight loss treatment accessible regardless of your coverage situation. Our providers focus on finding the most cost-effective approach for your individual circumstances, whether that means working with your insurance or providing competitive self-pay pricing.

Medication Costs

Out-of-pocket medication costs can be substantial:

• Wegovy: $1,300-$1,600/month without insurance
• Ozempic: $900-$1,000/month without insurance
• Mounjaro/Zepbound: $1,000-$1,400/month without insurance

Manufacturer savings programs can significantly reduce costs:

• Novo Nordisk (Wegovy, Ozempic) offers savings cards
• Eli Lilly (Mounjaro, Zepbound) provides copay assistance
• Eligibility typically requires commercial insurance (not Medicare/Medicaid)

Red Flags: How to Identify Illegitimate Telehealth Services

The popularity of weight loss medications has unfortunately attracted questionable operators. Watch out for these warning signs:

🚩 Guaranteed Prescriptions

Any service promising you’ll definitely get a prescription before you’ve completed a medical evaluation is not practicing legitimate medicine. Qualified providers must assess your individual health status and may determine the medication isn’t appropriate for you.

🚩 Compounded or ‘Generic’ Semaglutide

Following the FDA’s May 2025 ban on compounded semaglutide for weight loss, legitimate providers only prescribe FDA-approved branded medications. Be extremely cautious of any service offering:

• ‘Compounded semaglutide’ or ‘generic Wegovy’
• Significantly discounted ‘alternative’ formulations
• Medications shipped from overseas pharmacies
• Products without proper FDA approval

🚩 No Follow-up or Monitoring

Weight loss medication requires ongoing medical supervision. Services that don’t schedule regular follow-ups or offer no provider availability between appointments are not providing safe care.

🚩 Minimal Medical Evaluation

A legitimate evaluation requires:

• Detailed medical questionnaire
• Live video consultation with a licensed provider
• Discussion of risks, benefits, and alternatives
• Informed consent process
• Verification of eligibility criteria

If a service skips any of these steps, look elsewhere.

🚩 Unclear Provider Credentials

Reputable platforms clearly identify:

• The provider’s name and credentials (MD, DO, NP, PA)
• Their state license number and licensing state
• How to contact them with questions

Vague references to ‘our medical team’ without specific provider information is a red flag.

🚩 Lack of Transparency

Be wary of services that:

• Don’t clearly state total costs upfront
• Have no visible physical address or clinic affiliation
• Make exaggerated claims (‘Lose 50 pounds in 3 months!’)
• Require you to waive legal rights
• Pressure you to commit before speaking with a provider

Privacy and Data Security Considerations

Telehealth for weight loss involves particularly sensitive personal information. Ensure your provider:

Complies with HIPAA: All telehealth platforms must meet Health Insurance Portability and Accountability Act standards for protecting your medical information.

Uses secure technology: Video consultations should use encrypted platforms, not standard consumer apps like FaceTime or Zoom.

Respects state privacy laws: Some states have additional privacy protections beyond HIPAA. For example, Washington’s My Health My Data Act (2023) provides extra safeguards for health data, particularly relevant for weight-loss information that some might consider sensitive.

Has clear data policies: Read the privacy policy to understand how your information will be used, stored, and shared.

The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve in favor of expanded telehealth access:

Federal Developments

DEA Telehealth Extensions: While GLP-1 medications aren’t affected by DEA controlled substance rules, the agency’s repeated extensions of telehealth flexibilities (most recently through December 31, 2025) signal federal support for telemedicine. Another extension or permanent rule is expected for 2026.

Congressional Action: The TREATS Act, reintroduced in October 2025, would make certain telehealth prescribing flexibilities permanent. While focused on addiction treatment and mental health, its passage would demonstrate Congressional commitment to telehealth expansion.

Medicare Coverage: Ongoing advocacy efforts aim to persuade Medicare to cover anti-obesity medications, which would dramatically expand access for older Americans.

State Trends

Expanding NP Authority: Multiple states have bills pending to grant nurse practitioners full practice authority, which would increase the provider pool available for telehealth weight loss care. Mississippi, Pennsylvania, and several other states are considering such legislation in 2025-2026.

Standardizing Telehealth Rules: Interstate licensure compacts are making it easier for providers to be licensed in multiple states, improving access for patients regardless of location.

Easing In-Person Requirements: Several states that currently mandate initial in-person exams are reconsidering these rules based on evidence of telehealth safety and effectiveness.

What This Means for Patients

The future looks bright for telehealth access to weight loss treatment. Expect:

• More providers offering telehealth weight loss programs
• Increased insurance coverage as obesity treatment becomes more mainstream
• Greater convenience through app-based monitoring and asynchronous communication
• Lower costs as competition increases and more generic options eventually become available

Making Telehealth Work for Your Weight Loss Journey

If you’re considering telehealth for weight loss medication, here’s how to ensure a successful experience:

Choose a Reputable Provider

Look for platforms that:

• Clearly identify licensed providers and their credentials
• Require comprehensive medical evaluations
• Offer ongoing monitoring and support
• Accept insurance and provide transparent pricing
• Have positive patient reviews and established track records

Klarity Health offers accessible, affordable weight loss treatment through our network of licensed healthcare providers. We combine the convenience of telehealth with the thoroughness of in-person care, ensuring you receive safe, effective treatment tailored to your needs. Our providers are available when you need them, we accept both insurance and cash pay, and our pricing is always transparent—no hidden fees or surprise charges.

Be Honest and Thorough

For telehealth to work effectively:

• Provide complete and accurate medical history
• Disclose all medications and supplements you’re taking
• Report side effects promptly
• Be honest about your weight loss goals and concerns
• Follow through with recommended lab work and follow-up appointments

Commit to the Full Treatment Plan

GLP-1 medications are not magic pills. Success requires:

• Taking medication consistently as prescribed
• Making dietary changes to support weight loss
• Incorporating regular physical activity
• Attending follow-up appointments
• Being patient—meaningful weight loss takes months, not weeks

Know When Telehealth Isn’t Appropriate

Consider in-person care instead if you:

• Have complex medical conditions requiring hands-on examination
• Need procedures that can’t be done remotely (like certain lab work)
• Prefer face-to-face interactions with your healthcare team
• Live in a state with significant telehealth restrictions
• Have concerns that can’t be adequately addressed virtually

State-Specific Considerations: Making the Right Choice for Your Location

Your state of residence significantly impacts your telehealth options. Here’s how to navigate state-specific requirements:

If You Live in a Restrictive State

States like Arkansas, New Jersey, or Texas with stricter requirements don’t prohibit telehealth—they just add extra steps:

1. Plan for an initial in-person visit if required in your state
2. Understand follow-up requirements before starting treatment
3. Work with providers familiar with your state’s regulations
4. Consider nearby states’ rules if you live near a border and travel frequently

If You Travel Frequently

Telehealth prescribing requires the provider to be licensed in the state where you’re physically located during the consultation:

• Notify your provider if you’ll be in a different state during your appointment
• Ensure your provider has multi-state licenses if you split time between states
• Understand that prescriptions may need to be sent to different pharmacies depending on your location

If You’re Moving

If you relocate during treatment:

1. Inform your provider of your move as soon as possible
2. Verify they’re licensed in your new state
3. Understand you may need to switch providers if they can’t practice in your new location
4. Request medical records to ensure continuity of care
5. Research your new state’s requirements for ongoing treatment

Take the Next Step Toward Your Weight Loss Goals

Telehealth has transformed access to weight loss treatment, making FDA-approved medications like Wegovy, Ozempic, and Mounjaro available to millions of Americans who might not otherwise have convenient access to specialized care. While regulations vary by state, the overwhelming majority of people can legally access these medications through legitimate telehealth consultations.

The key is working with a reputable provider who prioritizes your safety, thoroughly evaluates your candidacy, and provides ongoing support throughout your weight loss journey.

Ready to explore whether telehealth weight loss treatment is right for you?

Klarity Health connects you with licensed healthcare providers who specialize in weight management. Our providers take time to understand your unique situation, work with your insurance when possible, and offer transparent cash-pay pricing. With provider availability that fits your schedule and ongoing support when you need it, Klarity makes professional weight loss care accessible and affordable.

Schedule your confidential consultation today to discuss your weight loss goals with a licensed provider who can help you determine if GLP-1 medications are appropriate for your situation.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider about your specific health needs and treatment options. Regulations regarding telehealth prescribing are subject to change; verify current rules in your state before beginning treatment.

Sources and References

This article was researched and fact-checked using current federal and state regulations, medical guidelines, and authoritative healthcare sources. Key references include:

1. DEA and HHS Announcement – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025,’ Drug Enforcement Administration official release, November 15, 2024. www.dea.gov

2. Axios News Report – ‘COVID-era telehealth prescribing extended,’ Axios, November 18, 2024. www.axios.com

3. McDermott Will & Emery Legal Analysis – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025,’ November 18, 2024. www.mwe.com

4. Goodwin Procter Client Alert – ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs,’ March 27, 2024. www.goodwinlaw.com

5. Reuters – ‘Hims & Hers to cut 4% of workforce amid ban on weight loss drug copies,’ May 30, 2025. www.reuters.com

Research current as of December 17, 2025. Federal telehealth rules for controlled substances are temporary (set to expire December 31, 2025) with additional extensions expected. State laws continue to evolve; patients should verify current regulations in their state before beginning treatment.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid